Cargando…
Comparison of outcomes following intravenous magnesium compared with intravenous labetalol and oral nifedipine in 355 pregnant Han Chinese women with preeclampsia
As per the American College of Obstetricians and Gynecologists in 2013, magnesium sulfate is the gold standard for the management of preeclampsia, but it has a short action time that does not provide stable maintenance of blood pressure. Labetalol is currently recommended as first-line treatment by...
Autores principales: | Peng, Zhouli, Zhang, Jidong, Xiao, Yuhui, Dong, Weiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659676/ https://www.ncbi.nlm.nih.gov/pubmed/37986315 http://dx.doi.org/10.1097/MD.0000000000035334 |
Ejemplares similares
-
Comparison of efficacy of intravenous labetalol and intravenous hydralazine for management of pre-eclampsia in pregnant women
por: Kausar, Mauzma, et al.
Publicado: (2023) -
Identification of SEPP1 polymorphisms is not a genetic risk factor for preeclampsia in Chinese Han women: A clinical trial and experimental study
por: Wu, Hong, et al.
Publicado: (2017) -
PTX3 Gene 3’UTR polymorphism and its interaction with environmental factors are correlated with the risk of preeclampsia in a Chinese Han population
por: Xu, Ning, et al.
Publicado: (2020) -
Oral nifedipine and phytosterol, intravenous nicardipine, and oral nifedipine only: Three-arm, retrospective, cohort study for management of severe preeclampsia
por: Ma, Shanduo, et al.
Publicado: (2023) -
Evaluation of intravenous infusion of labetalol versus magnesium sulfate on cerebral hemodynamics of preeclampsia patients with severe features using transcranial doppler
por: Mowafy, Sherif M. S., et al.
Publicado: (2023)